sSMC derived from chromosome (1 or) 5 or 19
|
Cases without clinical findings |
3 |
Cases with clinical findings |
3 |
| Cases with unclear clinical correlation |
|||
| In general 70% of sSMC carriers are clinically normal. The figures here are based partially on the bias, that mainly clinically aberrant cases are reported in literature! |
_______________________________________________________________________________________
Cases without clinical findings (O):
|
case no. |
gender |
age at diagnosis |
studied |
de novo/ |
GTG-banding result |
final FISH result of the sSMC |
FISH |
UPD |
clinical symptoms |
reference |
| 05/19-O-p11/ 1-1 |
female | 36y | PBL | n.a. | 47,XX,+mar[50%]/ 46,XX[50%] |
min(5)(:p11→q11.1:) or min(19)(:p11→q12:) | cenM, subcenM | n.a. | normal woman, unfulfilled wish for children | {0} provided by Wagner, Stibbe, Hannover, Germany |
O-cases with unclear/insufficient characterization of the sSMC itself (CO):
|
case no. |
gender |
age at diagnosis |
studied |
de novo/ |
GTG-banding result |
final FISH result of the sSMC |
FISH |
UPD |
clinical symptoms |
reference |
| 05/19-CO-1 | female | 1m | PBL cell line at ECACC DD0617 |
de novo | 47,XX,+mar[50%]/ 46,XX[50%] in cell line no marker acc to {5} |
mar(5 or 19) | FISH with all available centromeric probes |
no UPD 5 or 19: informative markers: D5S392; APOC2 |
clinically normal; studied due to failure to thrive, severe floppiness and pneumonia at 3w. | {1} case 20 {3} case 10 {5} case 16} |
| 05/19-CO-2 | male | prenatal | AF | de novo | 47,XY,+mar[28]/ 46,XY[22] |
r(1 or 19) | FISH with all available centromeric probes, telomeric probes | n.a. | Amniocentesis due to a Down syndrome risk of 1/170 on maternal serum triple marker screening, child born at 41 weeks gestation, and at three months of age was reported to be phenotypically normal. | {4} case 5 |
_______________________________________________________________________________________
Cases with clinical findings (W):
|
case no. |
gender |
age at diagnosis |
studied |
de novo/ |
GTG-banding result |
final FISH result of the sSMC |
FISH |
UPD |
clinical symptoms |
reference |
| 05/19-W-1 | male | child | PBL | n.a. | 47,XY+mar1[14]/ 47,XY,+mar2[2] | min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11) (mar2 is duplication of mar1) |
cenM, subcenM, 1q12 | n.a. | hyperactivity, short stature, high arched palate. Long face. Short fingers. relatively large penis | {0} provided by Dr. M. Sagai, Jerusalem, Israel |
W-cases with unclear/insufficient characterization of the sSMC itself (CW):
|
case no. |
gender |
age at diagnosis |
studied |
de novo/ |
GTG-banding result |
final FISH result of the sSMC |
FISH |
UPD |
clinical symptoms |
reference |
| 05/19-CW-1 | male |
prenatal |
CH/PBL | de novo | 47,XY,+mar1[27%]/ 47,XY,+mar2[13%]/ 47,XY,+mar3[20%]/ 46,XY[40%] (in CH mar in 60%; at birth mar in 60% of PBL; frequency given above is from 14m) |
mar1
= min(5
or 19) mar2 = dic(5 or 19) mar3 = ? |
FISH with all available centromeric probes | n.a. | Chorion biopsy due to advanced maternal age; at 14m large head (98. centile), frontal bossing, epicanthic folds, hypotonia, developmental delay. | {3} case 11 |
| 05/19-CW-2 | n.a. |
prenatal |
AF | de novo | 47,+mar[?%] | r(1 or 5 or 19) | n.a. | n.a. | cystic hygroma, TOP | {7} 1 case |
_______________________________________________________________________________________
Cases with unclear clinical correlation of the sSMC itself
(U):
|
case no. |
gender |
age at diagnosis |
studied |
de novo/ |
GTG-banding result |
final FISH result of the sSMC |
FISH |
UPD |
clinical symptoms |
reference |
| 05/19-U-1 | female | 7y | PBL cell line at ECACC DD1145 |
de novo | 47,XX,+mar[25]/ 46,XX[9] |
mar(5 or 19) | FISH with all available centromeric probes |
no UPD 5 or 19: informative markers: D5S392; APOC2 |
clinically normal according to {1}; large head, frontal bossing, hypotonia, epicanthic folds, developmental delay, floppy according to ECACC | {1}
case 19 {2} case 22 |
| 05/19-U-2 | female | prenatal | AF | de novo | 47,XX,+mar[80%]/ 46,XX[20%] |
min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11) | cenM; subcenM |
no UPD 19: informative markers: D19S1034, D19S245, D19S178, D19S589, D19S254 |
amniocentesis due to advanced maternal age; no further information available | {0} provided by Genteq, Hamburg, Germany |
| 05/19-U-3 | female | prenatal | AF | de novo | 47,XX,+mar[?100%] | min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11) | cenM; subcenM | n.a. | amniocentesis due to advanced maternal age; no US abnormalities. TOP. No dysmorphism in autopsy | {0} provided by Dr. Bhatt, Sucheta, USA |
| 05/19-U-4 to U5 | n.a. | n.a. | n.a. | n.a. | 47,+mar[?%] | mar(1/5/19) | centromeric probes | n.a. | no info available | {6}2 cases |
| 05/19-U-6 | moved to 19-U-17 | {0} provided by Dr. Eiben, Oberhausen, Germany | ||||||||
| 05/19-U-7 | female | prenatal | AF | n.a. |
47XX,+mar[27]/ 46,XX[11] |
min(5)(:p11→q11.1:) or min(19)(:p11→q12:) | cenM; subcenM | n.a. | amniocentesis due to advanced maternal age; No further info available | {0} provided by Dr. Mehnert, Neu-Ulm, Germany |
_______________________________________________________________________________________